UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neutron vs photon irradiation of inoperable salivary gland tumors: Results of an RTOG-MRC cooperative randomized study

International journal of radiation oncology, biology, physics, 1988-11, Vol.15 (5), p.1085-1090

1988

Volltextzugriff (PDF)

25

International journal of radiation oncology, biology, physics, 2006-11, Vol.66 (3), p.S14-S15

2006

Volltextzugriff (PDF)

The TAME Risk Classification System: Acute Toxicity Burden and IPD Analysis of RTOG 90–03

International journal of radiation oncology, biology, physics, 2005-10, Vol.63, p.S131-S131

2005

Volltextzugriff (PDF)

25: Long-Term Survival Results of a Phase III Intergroup Trial (RTOG 95-01) of Surgery Followed by Radiotherapy vs. Radiochemotherapy for Resectable High Risk Squamous Cell Carcinoma of the Head And Neck

International journal of radiation oncology, biology, physics, 2006, Vol.66 (3), p.S14-S15

2006

Volltextzugriff (PDF)

Long Term Outcomes of RTOG 90–03: A Comparison of Hyperfractionation and Two Variants of Accelerated Fractionation to Standard Fractionation Radiotherapy for Head and Neck Squamous Cell Carcinoma

International journal of radiation oncology, biology, physics, 2005-10, Vol.63, p.S70-S71

2005

Volltextzugriff (PDF)

Enhancing the therapeutic index of concomitant chemoradiotherapy for head and neck cancer

Annals of oncology, 1998-05, Vol.9 (5), p.471-473

1998

Volltextzugriff (PDF)

Astro plenary: Interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: Results from radiation therapy oncology group protocol 8313

International journal of radiation oncology, biology, physics, 1991-06, Vol.20 (6), p.1191-1195

1991

Volltextzugriff (PDF)

Microvessel density (mvd)≥60 does not predict for outcome in advanced head and neck squamous cell carcinoma (HNSCC): results of a prospective study from the RTOG 90-03 trial

International journal of radiation oncology, biology, physics, 2001-11, Vol.51 (3), p.41-41

2001

Volltextzugriff (PDF)

Patterns of failure for resected advanced head & neck cancer treated by concurrent chemotherapy and radiation therapy: an analysis of RTOG 9501/intergroup phase III trial

International journal of radiation oncology, biology, physics, 2002-10, Vol.54 (2), p.2-2

2002

Volltextzugriff (PDF)

Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long term results of a clinical cooperative group protocol, Trog 89-02

International journal of radiation oncology, biology, physics, 1998, Vol.42 (1), p.162-162

1998

Volltextzugriff (PDF)

1 A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: Preliminary results of RTOG 9003

International journal of radiation oncology, biology, physics, 1999, Vol.45 (3), p.145-145

1999

Volltextzugriff (PDF)

Diffuse malignant mesothelioma. Prospective evaluation of 69 patients

Annals of internal medicine, 1982-06, Vol.96 (6 Pt 1), p.746

1982

Volltextzugriff (PDF)

A Radiation Therapy Oncology Group (RTOG) phase III randomised study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas; first report of RTOG 9003

Cancer radiothérapie, 2001, Vol.5 (1), p.95-96

2001

Volltextzugriff (PDF)

Failure of misonidazole-sensitized radiotherapy to impact upon outcome among stage III–IV squamous cancers of the head and neck

International journal of radiation oncology, biology, physics, 1987-08, Vol.13 (8), p.1155-1160

1987

Volltextzugriff (PDF)

1007 The need for central pathology tumor grading in prostate cancer using radiation therapy oncology group(RTOG) 8531

International journal of radiation oncology, biology, physics, 1997, Vol.39 (2), p.219-219

1997

Volltextzugriff (PDF)

A comparison of misonidazole sensitized radiation therapy to radiation therapy alone for the palliation of hepatic metastases: Results of a radiation therapy oncology group randomized prospective trial

International journal of radiation oncology, biology, physics, 1987-07, Vol.13 (7), p.1057-1064

1987

Volltextzugriff (PDF)

RTOG clinical trials with etanidazole

European journal of cancer (1990), 1993, Vol.29, p.S19-S19

1993

Volltextzugriff (PDF)

Interruptions of high-dose radiation therapy for non-small cell carcinoma of the lung decrease long-term survival in favorable patients

International journal of radiation oncology, biology, physics, 1992, Vol.24, p.193-194

1992

Volltextzugriff (PDF)

The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)

International journal of radiation oncology, biology, physics, 1992, Vol.24, p.192-193

1992

Volltextzugriff (PDF)

Clinical experiences in multi-institutional trials-RTOG

European journal of cancer (1990), 1993, Vol.29, p.S43-S43

1993

Volltextzugriff (PDF)

Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13

International journal of radiation oncology, biology, physics, 1994, Vol.30, p.157-158

1994

Volltextzugriff (PDF)

Mixed neutron/photon irradiation of unresectable squamous cell carcinomas of the head and neck: The final report of a randomized cooperative trial

International journal of radiation oncology, biology, physics, 1989-11, Vol.17 (5), p.959-965

1989

Volltextzugriff (PDF)

Interfraction interval is major determinant of late effects, but not acute effects or tumor control, with hyperfractionated irradiation (HFX) of carcinomas of upper respiratory and digestive tracts (URDT)

International journal of radiation oncology, biology, physics, 1990, Vol.19, p.196-196

1990

Volltextzugriff (PDF)

Analysis of early and lats deaths on RTOG non-small cell lung carcinoma trials vs. CALGB 8433

International journal of radiation oncology, biology, physics, 1991, Vol.21, p.137-137

1991

Volltextzugriff (PDF)

Locally recurrent breast carcinoma: the effect of adjuvant chemotherapy on prognosis

Radiology, 1983-06, Vol.147 (3), p.849-852

1983

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(28)
Buchkapitel
(2)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

Humans
(10)
Female
(9)
Life Sciences & Biomedicine
(9)
Science & Technology
(9)
Male
(8)
Middle Aged
(8)
Biological And Medical Sciences
(7)
Medical Sciences
(7)
Adult
(6)
Aged
(6)
Oncology
(6)
Patients
(6)
Radiology, Nuclear Medicine & Medical Imaging
(6)
Radiotherapy
(6)
Diseases
(5)
Medicine
(5)
Neoplasms
(5)
Nuclear Medicine
(5)
Radiology
(5)
Radiology And Nuclear Medicine
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neutron vs photon irradiation of inoperable salivary gland tumors: Results of an RTOG-MRC cooperative randomized study

25

The TAME Risk Classification System: Acute Toxicity Burden and IPD Analysis of RTOG 90–03

25: Long-Term Survival Results of a Phase III Intergroup Trial (RTOG 95-01) of Surgery Followed by Radiotherapy vs. Radiochemotherapy for Resectable High Risk Squamous Cell Carcinoma of the Head And Neck

Long Term Outcomes of RTOG 90–03: A Comparison of Hyperfractionation and Two Variants of Accelerated Fractionation to Standard Fractionation Radiotherapy for Head and Neck Squamous Cell Carcinoma

Enhancing the therapeutic index of concomitant chemoradiotherapy for head and neck cancer

Astro plenary: Interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: Results from radiation therapy oncology group protocol 8313

Microvessel density (mvd)≥60 does not predict for outcome in advanced head and neck squamous cell carcinoma (HNSCC): results of a prospective study from the RTOG 90-03 trial

Patterns of failure for resected advanced head & neck cancer treated by concurrent chemotherapy and radiation therapy: an analysis of RTOG 9501/intergroup phase III trial

Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long term results of a clinical cooperative group protocol, Trog 89-02

1 A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: Preliminary results of RTOG 9003

Diffuse malignant mesothelioma. Prospective evaluation of 69 patients

A Radiation Therapy Oncology Group (RTOG) phase III randomised study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas; first report of RTOG 9003

Failure of misonidazole-sensitized radiotherapy to impact upon outcome among stage III–IV squamous cancers of the head and neck

1007 The need for central pathology tumor grading in prostate cancer using radiation therapy oncology group(RTOG) 8531

A comparison of misonidazole sensitized radiation therapy to radiation therapy alone for the palliation of hepatic metastases: Results of a radiation therapy oncology group randomized prospective trial

RTOG clinical trials with etanidazole

Interruptions of high-dose radiation therapy for non-small cell carcinoma of the lung decrease long-term survival in favorable patients

The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)

Clinical experiences in multi-institutional trials-RTOG

Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13

Mixed neutron/photon irradiation of unresectable squamous cell carcinomas of the head and neck: The final report of a randomized cooperative trial

Interfraction interval is major determinant of late effects, but not acute effects or tumor control, with hyperfractionated irradiation (HFX) of carcinomas of upper respiratory and digestive tracts (URDT)

Analysis of early and lats deaths on RTOG non-small cell lung carcinoma trials vs. CALGB 8433

Locally recurrent breast carcinoma: the effect of adjuvant chemotherapy on prognosis

Suchergebnisse filtern